ArticleScientific reports2026
Investigation of the molecular network underlying PET-MPs-induced inflammatory bowel disease via integrated machine learning and molecular docking approaches.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyethylene terephthalate microplastics (PET-MPs), as environmental contaminants, have raised significant concerns due to their potential toxicity, leading to serious environmental pollution and health issues. However, their impact on inflammatory bowel disease (IBD) remains poorly elucidated. This study aims to investigate the potential molecular mechanisms linking PET-MPs to IBD pathogenesis. Multiple datasets were employed to identify Crohn's disease (CD)- and ulcerative colitis (UC)-associated targets. Multi-machine learning approaches were combined with molecular docking of a PET-related compound to evaluate potential binding interactions with the identified hub targets. This study delineated 9 putative targets associated with PET-MPs-related CD pathogenesis and 17 potential targets associated with UC pathogenesis. For CD, GBM showed the best performance among all models, with a mean ROC-AUC of 0.862; for UC, RF performed best, with a mean ROC-AUC of 0.806, based on both training and validation sets. Multi-machine learning analysis identified 14 hub genes as candidate key regulatory factors. SHAP analysis highlighted their significant contributions to the model predictions. Molecular docking simulations suggested favorable binding affinities between a PET-related compound and the hub targets. This study suggests that PET-MPs may contribute to IBD pathogenesis by potentially interacting with 14 machine learning-prioritized hub genes. Molecular docking analyses indicated predicted high-affinity binding between a PET-related compound and these targets. Collectively, these findings provide a hypothesis-generating framework for investigating the potential role of PET-MPs in IBD progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.